GlassScriptPhysician profile
John K-S Lee
NPI 1811187099
$4,113.54
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,792 · 2020: $1,598 · 2021: $724.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $597.43 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $416.11 | 2019-2021 | |
| Daiichi Sankyo INC. | $412.59 | 2019 | |
| Amgen INC. | $411.15 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $285.36 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $236.93 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $233.52 | 2019-2021 | |
| Abbvie INC. | $185.95 | 2021 | |
| Lilly USA, LLC | $183.32 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $136.58 | 2019-2020 | |
| Redhill Biopharma INC. | $122.32 | 2020-2021 | |
| Mdd US Operations, LLC | $121.01 | 2019 | |
| Abbott Laboratories | $104.93 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $100.06 | 2020-2021 | |
| Pfizer INC. | $94.54 | 2019-2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $91.45 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.23 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $57.72 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $40.96 | 2020 | |
| Virtus Pharmaceuticals LLC | $36.41 | 2021 | |
| Vertical Pharmaceuticals, LLC | $28.70 | 2019 | |
| Supernus Pharmaceuticals, INC. | $28.61 | 2019 | |
| Kaleo, INC. | $21.72 | 2019 | |
| Assertio Therapeutics, INC. | $20.90 | 2019 | |
| Bausch Health US, LLC | $17.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $17.70 | 2019 | |
| Shionogi INC | $15.21 | 2019 | |
| Alfasigma USA, INC. | $13.21 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.